
CME Group Inc. (NASDAQ:CME – Free Report) – Analysts at Zacks Research dropped their FY2025 earnings estimates for CME Group in a report released on Wednesday, November 12th. Zacks Research analyst Team now anticipates that the financial services provider will earn $11.04 per share for the year, down from their prior forecast of $11.13. The consensus estimate for CME Group’s current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group’s Q3 2027 earnings at $3.44 EPS.
Several other analysts have also commented on the company. UBS Group dropped their target price on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a report on Thursday, October 23rd. Barclays lowered their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research report on Wednesday, October 8th. Morgan Stanley lifted their target price on shares of CME Group from $312.00 to $314.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. Raymond James Financial decreased their target price on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. Finally, TD Cowen raised their price target on shares of CME Group from $288.00 to $290.00 and gave the company a “hold” rating in a research report on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and an average target price of $287.65.
CME Group Stock Performance
NASDAQ CME opened at $285.04 on Friday. The firm has a market capitalization of $102.79 billion, a P/E ratio of 27.62, a PEG ratio of 4.41 and a beta of 0.38. The stock has a 50-day simple moving average of $267.33 and a two-hundred day simple moving average of $272.85. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a fifty-two week low of $222.56 and a fifty-two week high of $290.79.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period in the previous year, the firm posted $2.68 earnings per share.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently made changes to their positions in the stock. Jessup Wealth Management Inc boosted its stake in CME Group by 0.5% during the second quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock worth $2,197,000 after buying an additional 36 shares during the last quarter. First Horizon Advisors Inc. raised its holdings in shares of CME Group by 0.7% during the 2nd quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock worth $1,453,000 after acquiring an additional 36 shares during the period. Great Lakes Advisors LLC raised its holdings in shares of CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock worth $441,000 after acquiring an additional 37 shares during the period. MBM Wealth Consultants LLC boosted its position in shares of CME Group by 2.7% during the 2nd quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 37 shares during the last quarter. Finally, West Family Investments Inc. grew its holdings in shares of CME Group by 1.2% in the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after purchasing an additional 37 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at CME Group
In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of CME Group stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $263.53, for a total value of $263,530.00. Following the sale, the director owned 1,091 shares in the company, valued at $287,511.23. This trade represents a 47.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Sunil Cutinho sold 11,896 shares of the company’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 14,043 shares of company stock valued at $3,791,486. Insiders own 0.30% of the company’s stock.
CME Group Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a dividend of $1.25 per share. The ex-dividend date is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio is currently 48.45%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Are These 3 Oversold Tech Giants Ready to Rebound?
- How to Invest in the Best Canadian StocksĀ
- If You Wait for the Dip, Micron Technology Could Leave You Behind
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Stocks Quietly Powering the AI and Tech Revolution
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
